Acute hemodynamische impact van een intraveneuze glucose injectie

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-006965-18-BE

Enrollment

Registered

2007-01-23

Start date

2007-02-20

Completion date

Unknown

Last updated

2014-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneale Dialyse MedDRA version: 9.1 Level: LLT Classification code 10034660 Term: Peritoneal dialysis

Interventions

Trade Name: Glucose 20% Product Name: Glucose 20% Pharmaceutical Form: Solution for infusion INN or Proposed INN: Glucose Concentration unit: % percent Concentration type: equal Concentration number:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Peritoneal Dialysis since minimum 1 month - > 18 years old - Healthy subjects matched with PD patients - Stable clinical condition Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - Heart Failure - Diabetes requiring insulin treatment

Design outcomes

Primary

Measure	Time frame
Main Objective: To investigate whether the administration of glucose 20% IV has an haemodynamic impact.;Secondary Objective: ;Primary end point(s): Haemodynamic parameters	—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026